Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Waters (WAT)

Waters Corp Appoints Heather Knight, Baxter Executive, to Board of Directors

Neutral Impact 2 of 5 leadership Written later

Waters Corporation increased its board from 9 to 10 members and appointed Heather Knight, Executive Vice President and Group President of Medical Products and Therapies at Baxter International, effective August 14, 2024. Her compensation includes an initial equity grant valued at $91,666 and a prorated cash retainer of $54,130 through the 2025 annual meeting, which shareholders will see in the company's disclosures.

Key points

  • Board expanded from 9 to 10 members on August 13, 2024; Knight's appointment is effective August 14, 2024.
  • Knight currently serves as Executive Vice President and Group President, Medical Products and Therapies at Baxter International.
  • Initial equity grant valued at $91,666, split 50% restricted stock and 50% non-qualified stock options, vesting on the first anniversary of grant.
  • Prorated cash retainer of $54,130 for service until the 2025 annual meeting; the Board determined she is independent under NYSE standards.

The filing

CompanyWaters (WAT)
Form8-K, current report
Filed with the SECAug 14, 2024, 4:25 PM ET
Accession number0001193125-24-200650

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:30 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 14, 2024.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.